FDA Grants Premarket Approval (PMA) For The SEDASYS(R) System For Healthy Patients Undergoing Sedation During Routine Colonoscopy And EGD Procedures
Reduces risks associated with oversedation, facilitates faster patient recovery and increases physician satisfaction
CINCINNATI, May 3, 2013 -- (Healthcare Sales & Marketing Network) -- Sedasys, a Division of Ethicon Endo-Surgery, Inc. (Ethicon), today... Devices, Drug Delivery, Gastroenterology, Oncology, FDASedasys, Ethicon Endo-Surgery, Propofol, Colonoscopy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Cancer & Oncology | Colonoscopy | Diprivan | Gastroenterology | Grants | Marketing | Medical Ethics | Pharmaceuticals | Propofol